UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Improving drug delivery to primary and metastatic brain tumors: Strategies to overcome the blood-brain barrier

Clinical pharmacology and therapeutics, 2015-04, Vol.97 (4), p.336-346

2015

Volltextzugriff (PDF)

EGFRvIII stimulates glioma growth and invasion through PKA-dependent serine phosphorylation of Dock180

Oncogene, 2014-05, Vol.33 (19), p.2504-2512

2014

Volltextzugriff (PDF)

Identification and evaluation of a potent novel ATR inhibitor, NU6027, in breast and ovarian cancer cell lines

British journal of cancer, 2011-07, Vol.105 (3), p.372-381

2011

Volltextzugriff (PDF)

Oncolytic measles virus strains have significant antitumor activity against glioma stem cells

Gene therapy, 2013-04, Vol.20 (4), p.444-449

2013

Volltextzugriff (PDF)

p53 isoform profiling in glioblastoma and injured brain

Oncogene, 2013-06, Vol.32 (26), p.3165-3174

2013

Volltextzugriff (PDF)

Inhibition of ATM and ATR kinase activities by the radiosensitizing agent, caffeine

Cancer research (Chicago, Ill.), 1999-09, Vol.59 (17), p.4375-4382

1999

Volltextzugriff (PDF)

A role for ATR in the DNA damage-induced phosphorylation of p53

Genes & development, 1999-01, Vol.13 (2), p.152-157

1999

Volltextzugriff (PDF)

Chemically Modified Variants of Fenofibrate with Antiglioblastoma Potential

Translational oncology, 2019-07, Vol.12 (7), p.895-907

2019

Volltextzugriff (PDF)

Alisertib demonstrates significant antitumor activity in bevacizumab resistant, patient derived orthotopic models of glioblastoma

Journal of neuro-oncology, 2017-01, Vol.131 (1), p.41-48

2017

Volltextzugriff (PDF)

The radiosensitizing agent 7-hydroxystaurosporine (UCN-01) inhibits the DNA damage checkpoint kinase hChk1

Cancer research (Chicago, Ill.), 2000-04, Vol.60 (8), p.2108-2112

2000

Volltextzugriff (PDF)

Efficacy of the MDM2 inhibitor SAR405838 in PDX models of GBM is limited by active efflux at the BBB

European journal of cancer (1990), 2016-12, Vol.69, p.S67-S67

2016

Volltextzugriff (PDF)

Inhibition of phosphoinositide 3-kinase related kinases by the radiosensitizing agent Wortmannin

Cancer research (Chicago, Ill.), 1998-10, Vol.58 (19), p.4375-4382

1998

Volltextzugriff (PDF)

Experimental design recommendations for PDX pre-clinical trials: Reanalysis of radiation and temozolomide orthotopic survival data in GBM models

European journal of cancer (1990), 2016-12, Vol.69, p.S58-S58

2016

Volltextzugriff (PDF)

Spatially graded hydrogels for preclinical testing of glioblastoma anticancer therapeutics

MRS communications, 2017-09, Vol.7 (3), p.442-449

2017

Volltextzugriff (PDF)

259 Factors that limit delivery of Cdk4/6 inhibitor palbociclib to GBM

European journal of cancer (1990), 2014-11, Vol.50, p.86-86

2014

Volltextzugriff (PDF)

12 Next generation sequencing (NGS) guided therapy prediction for the treatment of glioblastoma multiforme (GBM)

European journal of cancer (1990), 2014-11, Vol.50, p.10-11

2014

Volltextzugriff (PDF)

The histone H3.3K27M mutation in pediatric glioma reprograms H3K27 methylation and gene expression

Genes & development, 2013-05, Vol.27 (9), p.985-990

2013

Volltextzugriff (PDF)

High-dose-rate versus low-dose-rate brachytherapy in the treatment of cervical cancer: analysis of tumor recurrence—the University of Wisconsin experience

International journal of radiation oncology, biology, physics, 1999-12, Vol.45 (5), p.1267-1274

1999

Volltextzugriff (PDF)

Disruption of Parallel and Converging Signaling Pathways Contributes to the Synergistic Antitumor Effects of Simultaneous mTOR and EGFR Inhibition in GBM Cells

Neoplasia (New York, N.Y.), 2005-10, Vol.7 (10), p.921-929

2005

Volltextzugriff (PDF)

RM-04 RETINOBLASTOMA BINDING PROTEIN 4 (RBBP4) MODULATES TEMOZOLOMIDE RESPONSE THROUGH REGULATION OF MGMT EXPRESSION IN GLIOBLASTOMA

Neuro-oncology (Charlottesville, Va.), 2014-11, Vol.16 (suppl 5), p.v186-v186

2014

Volltextzugriff (PDF)

The adverse effect of treatment prolongation in cervical carcinoma

International journal of radiation oncology, biology, physics, 1995-07, Vol.32 (5), p.1301-1307

1995

Volltextzugriff (PDF)

WE‐G‐214‐02: Utility of 18F‐FDOPA PET for Radiotherapy Target Delineation in Glioma Patients

Medical Physics, 2011-06, Vol.38 (6), p.3830-3830

2011

Volltextzugriff (PDF)

p16-Cdk4-Rb axis controls sensitivity to a cyclin-dependent kinase inhibitor PD0332991 in glioblastoma xenograft cells

Neuro-oncology (Charlottesville, Va.), 2012-07, Vol.14 (7), p.870-881

2012

Volltextzugriff (PDF)

Oral tongue cancer in young adults less than 40 years of age: Rationale for aggressive therapy

Head & neck, 1994-03, Vol.16 (2), p.107-111

1994

Volltextzugriff (PDF)

267 (PB255): Defining the spectrum of response and radiosensitizing potential of WSD0628 in brain patient-derived xenografts (PDX) models

European journal of cancer (1990), 2024-10, Vol.211, p.114782, Article 114782

2024

Volltextzugriff (PDF)

1 – 25 von 383

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(357)
Mit Volltextzugriff
(335)

Publikationsform

Sprache

Englisch
(383)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

Menü

Weitere Dienste

Einstellungen

Improving drug delivery to primary and metastatic brain tumors: Strategies to overcome the blood-brain barrier

EGFRvIII stimulates glioma growth and invasion through PKA-dependent serine phosphorylation of Dock180

Identification and evaluation of a potent novel ATR inhibitor, NU6027, in breast and ovarian cancer cell lines

Oncolytic measles virus strains have significant antitumor activity against glioma stem cells

p53 isoform profiling in glioblastoma and injured brain

Inhibition of ATM and ATR kinase activities by the radiosensitizing agent, caffeine

A role for ATR in the DNA damage-induced phosphorylation of p53

Chemically Modified Variants of Fenofibrate with Antiglioblastoma Potential

Alisertib demonstrates significant antitumor activity in bevacizumab resistant, patient derived orthotopic models of glioblastoma

The radiosensitizing agent 7-hydroxystaurosporine (UCN-01) inhibits the DNA damage checkpoint kinase hChk1

Efficacy of the MDM2 inhibitor SAR405838 in PDX models of GBM is limited by active efflux at the BBB

Inhibition of phosphoinositide 3-kinase related kinases by the radiosensitizing agent Wortmannin

Experimental design recommendations for PDX pre-clinical trials: Reanalysis of radiation and temozolomide orthotopic survival data in GBM models

Spatially graded hydrogels for preclinical testing of glioblastoma anticancer therapeutics

259 Factors that limit delivery of Cdk4/6 inhibitor palbociclib to GBM

12 Next generation sequencing (NGS) guided therapy prediction for the treatment of glioblastoma multiforme (GBM)

The histone H3.3K27M mutation in pediatric glioma reprograms H3K27 methylation and gene expression

High-dose-rate versus low-dose-rate brachytherapy in the treatment of cervical cancer: analysis of tumor recurrence—the University of Wisconsin experience

Disruption of Parallel and Converging Signaling Pathways Contributes to the Synergistic Antitumor Effects of Simultaneous mTOR and EGFR Inhibition in GBM Cells

RM-04 RETINOBLASTOMA BINDING PROTEIN 4 (RBBP4) MODULATES TEMOZOLOMIDE RESPONSE THROUGH REGULATION OF MGMT EXPRESSION IN GLIOBLASTOMA

The adverse effect of treatment prolongation in cervical carcinoma

WE‐G‐214‐02: Utility of 18F‐FDOPA PET for Radiotherapy Target Delineation in Glioma Patients

p16-Cdk4-Rb axis controls sensitivity to a cyclin-dependent kinase inhibitor PD0332991 in glioblastoma xenograft cells

Oral tongue cancer in young adults less than 40 years of age: Rationale for aggressive therapy

267 (PB255): Defining the spectrum of response and radiosensitizing potential of WSD0628 in brain patient-derived xenografts (PDX) models

Suchergebnisse filtern